Abstract | OBJECTIVES: METHODS: We evaluated 92 children presenting with daytime wetting, with or without nocturnal enuresis, who were receiving oral oxybutynin treatment. Children with chronic urinary tract infections, a neurologic lesion, an anatomic abnormality of lower urinary tract, voiding abnormality, and less than 1 year of oxybutynin treatment were excluded. Of the remaining 41 children (mean age 7.2 years, range 5 to 14 years), 30 agreed to switch to tolterodine and 11 continued receiving oxybutynin. Anticholinergic side effects, compliance, and clinical efficacy were assessed in the follow-up. RESULTS: Of the 30 patients who switched to tolterodine, a complete response was in 18 patients (60%), partial improvement in 11 (37%), and no improvement in 1 (3%) after a mean of 14.4 months (range 12 to 16 months) of oxybutynin treatment. The anticholinergic side-effect score was 7.2, 9.3, and 11, respectively, for those with a complete response, partial improvement, and no improvement in the compliant group. The noncompliant group had the greatest side-effect score (16.9). The fairly compliant group had a side-effect score of 12.3. After a mean of 7.1 months (range 6 to 9 months) of tolterodine use, a complete response was reported in 24 patients and partial improvement in 5 (17%). In 1 patient, treatment failed completely. However, his side-effect score decreased from 11 to 2. All tolterodine users were compliant with treatment. CONCLUSIONS:
|
Authors | Selcuk Yucel, Erdem Akkaya, Erol Guntekin, Erdal Kukul, Ahmet Danisman, Sema Akman, Mehmet Baykara |
Journal | Urology
(Urology)
Vol. 65
Issue 2
Pg. 369-73
(Feb 2005)
ISSN: 1527-9995 [Electronic] United States |
PMID | 15708055
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Benzhydryl Compounds
- Cholinergic Antagonists
- Cresols
- Mandelic Acids
- Phenylpropanolamine
- Tolterodine Tartrate
- oxybutynin
|
Topics |
- Adolescent
- Behavior Therapy
- Benzhydryl Compounds
(therapeutic use)
- Child
- Child, Preschool
- Cholinergic Antagonists
(therapeutic use)
- Combined Modality Therapy
- Cresols
(therapeutic use)
- Drug Evaluation
- Drug Resistance
- Female
- Follow-Up Studies
- Humans
- Male
- Mandelic Acids
(therapeutic use)
- Patient Compliance
- Phenylpropanolamine
(therapeutic use)
- Tolterodine Tartrate
- Urinary Incontinence
(drug therapy, therapy)
|